ENAVATE SCIENCES GP, LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, ENAVATE SCIENCES GP, LLC held in its portfolio 7 assets valued at $506,782,253 (i.e. $506.78M).

The most valuable assets in the portfolio included: ZENAS BIOPHARMA INC ($142.31M), IMMUNOME INC ($102.43M), and SIONNA THERAPEUTICS INC ($101.95M).

The chart below shows the top 7 valuable assets, and the table below shows the top 7 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in ENAVATE SCIENCES GP, LLC Portfolio

ZENAS BIOPHARMA INC

IMMUNOME INC

SIONNA THERAPEUTICS INC

UPSTREAM BIO INC

COMPASS THERAPEUTICS INC

BRIDGEBIO ONCOLOGY THERAPEUT

CAMP4 THERAPEUTICS CORP

ENAVATE SCIENCES GP, LLC - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
ZENAS BIOPHARMA INC	3919159	142304663	COM
IMMUNOME INC	4768583	102429163	COM
SIONNA THERAPEUTICS INC	2478030	101946154	COM
UPSTREAM BIO INC	2459703	66780936	COM
COMPASS THERAPEUTICS INC	7788150	41822366	COM
BRIDGEBIO ONCOLOGY THERAPEUT	2626946	32889364	COM NEW
CAMP4 THERAPEUTICS CORP	3035825	18609607	COM